Will Burlingham awarded grant for immunosuppression research

Dr. Burlingham (right) with collaborator Dr. Dixon Kaufman.

Congratulations to Will Burlingham, PhD, who received an NIH R21 grant for his project, “Exosome-mediated Tolerance in Combined Kidney and Stem Cell Transplantation.” This research will study whether renal transplant patients make tolerogenic virus-sized particles (known as extracellular vesicles (EV)) in response to their donor. It will also investigate if these patients, when deliberately weaned off immunosuppressive drug therapy in a clinical tolerance trial currently being run by Dixon Kaufman, MD, PhD, make even more EV, completely replacing their need for immunosuppressive drugs with their own “natural” form of immunosuppression.

Learn more about the Burlingham lab >>